Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors

Blood

Volumn 94, Issue 5, 1999, Pages 1601-1613

  Fichelson, Serge ^a   Freyssinier, Jean Marc ^a   Picard, Françoise ^a   Fontenay Roupie, Michaela ^a   Guesnu, Martine ^a   Cherai, Mustapha ^a   Gisselbrecht, Sylvie ^a   Porteu, Françoise ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CD34 ANTIGEN; FIBRINOGEN RECEPTOR; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL ESTER;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; COLONY FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ERYTHROLEUKEMIA CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; NEWBORN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0033199619     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1601.417k19_1601_1613     Document Type: Article

References (66)

1. Zucker-Franklin D, Kaushansky K: Effect of thrombopoietin on the development of megakaryocytes and platelets: An ultrastructural analysis. Blood 88:1632, 1996
2. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M: Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89:5640, 1992
3. De Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg Jr LA, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
4. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Balley MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369: 568, 1994
5. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chnag MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewther LA, Clogston C, Hsu E, Hokom MM, Homkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacbosen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
6. Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P: The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human magakaryocyte progenitors. Blood 86:2516, 1995
7. Kimura S, Roberts AW, Metcalf D, Alexander WS: Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci USA 95:1195, 1998
8. Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, De Sauvage FJ, Eaton DL: Role of c-Mpl in early hematopoiesis. Blood 92:4, 1998
9. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966, 1994
10. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841, 1994
11. Sundaram M, Han M: Control and integration of cell signaling pathways during C. elegans vulval development. Bioessays 18:473, 1996
12. O'Neill EM, Rebay I, Tijian R, Rubin GM: The activities of two ets-related transcription factors required for drosophila eye development are modulated by the ras/MPK pathway. Cell 78:137, 1994
13. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P: Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem J 288:351, 1992
14. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM: Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373:620, 1995
15. Crompton T, Gilmour KC, Owen MJ: The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell 86:243, 1996
16. Iritani BM, Forbush KA, Farrar MA, Perlmutter R: Control of B cell development by Ras-mediated activation of Raf. EMBO J 16:7019, 1997
17. Dhanasekaran N, Premkumar Reddy E: Signaling by dual specificity kinases. Oncogene 17:1447, 1998
18. Sturgill TW, Ray LB, Erikson E, Maller JL: Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715, 1988
19. 2 is phosphorylated and activated by MAP kinase. Cell 72:269, 1993
20. Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, Cobb MH: Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605, 1998
21. Treisman R: Regulation of transcription by MAP kinase cascade. Curr Opin Cell Biol 8:205, 1996
22. Porteu F, Rouyez MC, Cocault L, Bénit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I: Functional region of the mouse thrombopoietin receptor cytoplasmic domain: Evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol 16:2473, 1996
23. Alexander WS, Maurer AB, Novak U, Harrison-Smith M: Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. EMBO J 15:6531, 1996
24. Fukunaga R, Ishizaka-Ikeda E, Nagata S: Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 74:1079, 1993
25. Ryan JJ, McReynolds U, Keegan A, Wang LH, Garfein E, Rothman P, Nelms K, Paul WE: Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123, 1996
26. Corcoran AE, Smart FM, Cowling RJ, Crompton T, Owen MJ, Venkitaraman AR: The interleukin-7 receptor α chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J 15:1924, 1996
27. Matsuguchi T, Lilly MB, Kraft AS: Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor β chain (hβc) responsible for human GM-CSF-induced myeloid cell differentiation. J Biol Chem 273:19411, 1998
28. Ihle JN: Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Adv Cancer Res 68:23, 1996
29. Rouyez MC, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F: Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol 17:4991, 1997
30. Whalen AM, Galasinski SC, Shapiro PS, Stines Nahreini T, Ahn NG: Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol 17:1947, 1997
31. Racke FK, Lewandowska K, Goueli S, Goldfarb AN: Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem 272:23366, 1997
32. Melemed AS, Ryder JW, Vik TA: Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. Blood 90:3462, 1997
33. Drachman JG, Sabath DF, Fox NE, Kaushansky K: Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 89:483, 1997
34. Lin AW, Barradas M, Stone JC, Van Aelst L, Serrano M, Lowe SW: Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12:3008, 1998
35. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686, 1995
36. Fortunel N, Batard P, Hatzfeld A, Monier MN, Panterne B, Lebkovski J, Hatzfeld J: High proliferative potential-quiescent cells: A working model to study primitive quiescent hematopoietic cells. J Cell Sci 111:1813, 1998
37. Debili N, Issaad C, Massé JM, Guichard J, Katz A, Breton-Gorius J, Vainchenker W: Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 80:3022, 1992
38. + cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Exp Hematol 24:236, 1996
39. Higuchi T, Koike K, Sawai N, Koike T: Proliferation and differentiative potential of thrombopoietin-responsive precursors: Expression of megakaryocytic and erythroid lineage. Exp Hematol 25:463, 1997
40. Schipper LF, Brand A, Reniers NCM, Melief CJM, Willemze R, Fibbe WE: Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haematopoietic progenitor cells in cord blood. Br J Haematol 101:425, 1998
41. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489, 1995
42. Börsch-Haubold A, Pasquet S, Watson SP: Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. J Biol Chem 273:28766, 1998
43. Zutter MM, Painter AD, Yang X: The megakaryocyte/platelet-specific enhancer of the α2β1 integrin gene: Two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade. Blood 93:1600, 1999
44. Pumiglia KM, Decker SJ: Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448, 1997
45. Cip1. Mol Cell Biol 17:5598, 1997
46. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G: Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544, 1997
47. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P: The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 330:1451, 1998
48. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179, 1995
49. Muszynski KW, Ruscetti FW, Heidecker G, Rapp U, Troppmair J, Gooya JM, Keller JR: Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells. J Exp Med 181:2189, 1995
50. Sui X, Krantz SB, You M, Zhao Z: Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood 92:1142, 1998
51. Nagata Y, Takahashi N, Davis RJ, Todokoro K: Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92:1859, 1998
52. Perkins GR, Marshall CJ, Collins MKL: The role of MAP kinase kinase in interleukin-3 stimulation of proliferation. Blood 87:3669, 1996
53. Kinoshita T, Yokota T, Arai KI, Miyajima A: Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 14:266, 1995
54. Gobert S, Duprez V, Lacombe C, Gisselbrecht S, Mayeux P: The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells. Eur J Biochem 234:75, 1995
55. Mu SX, Xia M, Elliott G, Bogenberger J, Swift S, Bennett L, Lappinga DL, Hecht R, Lee R, Saris CJM: Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells. Blood 86:4532, 1995
56. Pallard C, Gouilleux F, Bénit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I: Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 14:2847, 1995
57. Drachman JG, Griffin JD, Kaushansky K: The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J Biol Chem 270:4979, 1995
58. Nagata Y, Nishida E, Todokoro K: Activation of JNK pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89:2664, 1997
59. Gurney AL, Wong SC, Henzel WJ, De Sauvage FJ: Distinct regions of c-Mpl cyloplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci USA 92:5292, 1995
60. Matsumura I, Nakajima K, Wakao H, Hattori S, Hashimoto K, Sugahara H, Kato T, Miyazaki H, Hirano T, Kanakura Y: Involvement of prolonged Ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol 18:4282, 1998
61. Brennan P, Babbage JW, Burgering BMT, Groner B, Reif K, Cantrell DA: Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679, 1997
62. Debili N, Coulombel L, Croisille L, Katz A, Guichard J, Breton-Gorius J, Vainchenker W: Characterization of a bipotent erythromegakaryocytic progenitor in human bone marrow. Blood 88:1284, 1996
63. Sharp LL, Schwarz DA, Bott CM, Marshall CJ, Hedrick SM: The influence of the MAPK pathway on T cell lineage commitment. Immunity 7:609, 1997
64. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80:199, 1995
65. Wen Z, Zhong Z, Darnell JE Jr: Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell 82:241, 1995
66. Scheid MP, Duronio V: Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation. Proc Natl Acad Sci USA 95:7439, 1998